Osimertinib vs Erlotinib or Gefitinib in Patients With EGFR-Mutated Advanced Non–Small Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer